DrugsControl Media Services

News Detail

Ruling Against Novartis Could Have Wider Implications for Generic Drug Labels (23-12-2017)

San Francisco, 22 Dec 2017: California's Supreme Court on Thursday ruled against Novartis in a decision that could have wider implications for whether brand-name or generic drugmakers should be held liable for warning consumers of risks in their drug labels.


View Details
Source : Regulatory Focus

Related News